BNP Paribas Financial Markets’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
172,446
+83,666
| +94% | +$787K | ﹤0.01% | 1955 |
|
|
2025
Q1 | $481K | Buy |
88,780
+1,971
| +2% | +$10.7K | ﹤0.01% | 2412 |
|
|
2024
Q4 | $647K | Buy |
+86,809
| New | +$647K | ﹤0.01% | 2331 |
|
|
2022
Q4 | – | Sell |
-9,790
| Closed | -$77.4K | – | 3541 |
|
|
2022
Q3 | $77.4K | Buy |
+9,790
| New | +$77.4K | ﹤0.01% | 3153 |
|
|
2020
Q4 | – | Sell |
-941
| Closed | -$4.87K | – | 3497 |
|
|
2020
Q3 | $4.87K | Sell |
941
-1,967
| -68% | -$10.2K | ﹤0.01% | 3385 |
|
|
2020
Q2 | $22K | Buy |
2,908
+969
| +50% | +$7.34K | ﹤0.01% | 2728 |
|
|
2020
Q1 | $19.8K | Buy |
1,939
+1,214
| +167% | +$12.4K | ﹤0.01% | 3299 |
|
|
2019
Q4 | $11.2K | Buy |
725
+419
| +137% | +$6.49K | ﹤0.01% | 3445 |
|
|
2019
Q3 | $5.54K | Buy |
+306
| New | +$5.54K | ﹤0.01% | 3610 |
|